...
首页> 外文期刊>Naunyn-Schmiedeberg's Archives of Pharmacology >Open channel block of Kv1.3 by rosiglitazone and troglitazone: Kv1.3 as the pharmacological target for rosiglitazone
【24h】

Open channel block of Kv1.3 by rosiglitazone and troglitazone: Kv1.3 as the pharmacological target for rosiglitazone

机译:罗格列酮和曲格列酮对Kv1.3的开放通道阻滞作用:Kv1.3作为罗格列酮的药理靶标

获取原文
获取原文并翻译 | 示例
           

摘要

The effects of rosiglitazone and troglitazone were examined on cloned Kv1.3 channels stably expressed in Chinese hamster ovary cells using the whole-cell configuration of the patch-clamp technique. Rosiglitazone decreased the Kv1.3 currents and accelerated the decay rate of current inactivation in a concentration-dependent manner with an IC50 of 18.6 μM. These effects were reversible after washout of the drug. Troglitazone caused the block of Kv1.3 with a similar pattern but was five times more potent than rosiglitazone with an IC50 of 3.5 μM. The block of Kv1.3 by rosiglitazone and troglitazone was voltage-dependent at a membrane potential coinciding with the activation of the channels. Both drugs decreased the tail current amplitude and slowed the deactivation process of Kv1.3, resulting in a tail crossover phenomenon. These results indicate that rosiglitazone and troglitazone block the open state of Kv1.3 channels, suggesting that it is an important pharmacological target for rosiglitazone as a potent blocker of Kv1.3 channels.
机译:使用膜片钳技术的全细胞构型,研究了罗格列酮和曲格列酮对在中国仓鼠卵巢细胞中稳定表达的克隆Kv1.3通道的影响。罗格列酮以浓度依赖性的方式降低了Kv1.3电流,并加速了电流失活的衰减速率,IC50 为18.6μM。冲洗药物后,这些作用是可逆的。曲格列酮引起的Kv1.3阻滞具有相似的模式,但效力是罗格列酮的五倍,IC50为3.5μM。罗格列酮和曲格列酮对Kv1.3的阻滞在膜电位上与电压有关,该电位与通道的激活相吻合。两种药物均降低了尾电流幅度并减慢了Kv1.3的失活过程,从而导致了尾巴交叉现象。这些结果表明罗格列酮和曲格列酮阻断了Kv1.3通道的开放状态,表明它是罗格列酮作为Kv1.3通道的强效阻断剂的重要药理靶标。

著录项

  • 来源
  • 作者单位

    Department of Physiology Medical Research Center College of Medicine The Catholic University of Korea 505 Banpo-dong Socho-gu Seoul 137-701 South Korea;

    Department of Physiology Medical Research Center College of Medicine The Catholic University of Korea 505 Banpo-dong Socho-gu Seoul 137-701 South Korea;

    Department of Physiology Medical Research Center College of Medicine The Catholic University of Korea 505 Banpo-dong Socho-gu Seoul 137-701 South Korea;

    Department of Physiology Medical Research Center College of Medicine The Catholic University of Korea 505 Banpo-dong Socho-gu Seoul 137-701 South Korea;

    Department of Physiology Medical Research Center College of Medicine The Catholic University of Korea 505 Banpo-dong Socho-gu Seoul 137-701 South Korea;

    Department of Physiology Medical Research Center College of Medicine The Catholic University of Korea 505 Banpo-dong Socho-gu Seoul 137-701 South Korea;

    Department of Physiology Medical Research Center College of Medicine The Catholic University of Korea 505 Banpo-dong Socho-gu Seoul 137-701 South Korea;

    Department of Physiology Medical Research Center College of Medicine The Catholic University of Korea 505 Banpo-dong Socho-gu Seoul 137-701 South Korea;

    Department of Pharmacology Medical Research Center College of Medicine The Catholic University of Korea 505 Banpo-dong Socho-gu Seoul 137-701 South Korea;

    Department of Pharmacology Medical Research Center College of Medicine The Catholic University of Korea 505 Banpo-dong Socho-gu Seoul 137-701 South Korea;

    Department of Physiology Medical Research Center College of Medicine The Catholic University of Korea 505 Banpo-dong Socho-gu Seoul 137-701 South Korea;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Thiazolidinedione; Voltage-gated K+ channel; Insulin sensitizer;

    机译:噻唑烷二酮;电压门控钾离子通道;胰岛素增敏剂;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号